The American Journal of Medicine
Volume 122, Issue 9 , Pages 836-842 , September 2009

Do NSAIDs Affect Longitudinal Changes in Knee Cartilage Volume and Knee Cartilage Defects in Older Adults?

  • Changhai Ding, MD

      Affiliations

    • Menzies Research Institute, University of Tasmania, Hobart, Australia
    • Department of Epidemiology and Preventive Medicine, Monash University Medical School, Melbourne, Australia
    • Corresponding Author InformationRequests for reprints should be addressed to Changhai Ding, MD, Menzies Research Institute, Private Bag 23, Hobart, Tasmania 7000, Australia
    • ,
  • Flavia Cicuttini, PhD

      Affiliations

    • Department of Epidemiology and Preventive Medicine, Monash University Medical School, Melbourne, Australia
    • ,
  • Graeme Jones, MD

      Affiliations

    • Menzies Research Institute, University of Tasmania, Hobart, Australia

References 

  1. Felson DT. Clinical practice (Osteoarthritis of the knee). N Engl J Med. 2006;354:841–848
  2. Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005;352:1092–1102
  3. Barozzi N, Tett SE. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?. Pharmacoepidemiol Drug Saf. 2007;16:1184–1191
  4. Abramson SB. Do nonsteroidal anti-inflammatory drugs accelerate disease progression in osteoarthritis?. Nat Clin Pract Rheumatol. 2006;2:302–303
  5. Ding C. Do NSAIDs affect the progression of osteoarthritis?. Inflammation. 2002;26:139–142
  6. Gencosmanoglu BE, Eryavuz M, Dervisoglu S. Effects of some nonsteroidal anti-inflammatory drugs on articular cartilage of rats in an experimental model of osteoarthritis. Res Exp Med (Berl). 2001;200:215–226
  7. Mastbergen SC, Jansen NW, Bijlsma JW, Lafeber FP. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study. Arthritis Res Ther. 2006;8:R2
  8. Mastbergen SC, Marijnissen AC, Vianen ME, et al. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis. Rheumatology (Oxford). 2006;45:405–413
  9. El Hajjaji H, Marcelis A, Devogelaer JP, Manicourt DH. Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage. J Rheumatol. 2003;30:2444–2451
  10. Reijman M, Bierma-Zeinstra SM, Pols HA, et al. Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? (The Rotterdam Study). Arthritis Rheum. 2005;52:3137–3142
  11. Ding C, Cicuttini F, Jones G. How important is MRI for detecting early osteoarthritis?. Nat Clin Pract Rheumatol. 2008;4:4–5
  12. Ding C, Cicuttini F, Scott F, et al. Sex differences in knee cartilage volume in adults: role of body and bone size, age and physical activity. Rheumatology (Oxford). 2003;42:1317–1323
  13. Jones G, Glisson M, Hynes K, Cicuttini F. Sex and site differences in cartilage development: a possible explanation for variations in knee osteoarthritis in later life. Arthritis Rheum. 2000;43:2543–2549
  14. Jones G, Ding C, Scott F, et al. Early radiographic osteoarthritis is associated with substantial changes in cartilage volume and tibial bone surface area in both males and females. Osteoarthritis Cartilage. 2004;12:169–174
  15. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–1840
  16. Ding C, Cicuttini F, Blizzard L, Jones G. Smoking interacts with family history with regard to knee cartilage loss and cartilage defect development. Arthritis Rheum. 2007;56:1521–1528
  17. Ding C, Garnero P, Cicuttini F, et al. Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown. Osteoarthritis Cartilage. 2005;13:198–205
  18. Ding C, Cicuttini F, Scott F, et al. Natural history of knee cartilage defects and factors affecting change. Arch Intern Med. 2006;166:651–658
  19. Zhai G, Stankovich J, Cicuttini F, et al. Familial, structural, and environmental correlates of MRI-defined bone marrow lesions: a sibpair study. Arthritis Res Ther. 2006;8:R137
  20. Collier S, Ghosh P. Comparison of the effects of non-steroidal anti-inflammatory drugs (NSAIDs) on proteoglycan synthesis by articular cartilage explant and chondrocyte monolayer cultures. Biochem Pharmacol. 1991;41:1375–1384
  21. Dingle JT. The effect of nonsteroidal antiinflammatory drugs on human articular cartilage glycosaminoglycan synthesis. Osteoarthritis Cartilage. 1999;7:313–314
  22. Dieppe P, Cushnaghan J, Jasani MK, et al. A two-year, placebo-controlled trail of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint. Br J Rheumatol. 1993;32:595–600
  23. Williams HJ, Ward JR, Egger MJ, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum. 1993;36:1196–1206
  24. Ding C. Does diclofenac induce accelerated progression of hip and knee radiographic osteoarthritis? (Comment on the article by Reijman et al). Arthritis Rheum. 2006;54:1027;author reply 1028
  25. McGibbon CA, Trahan CA. Measurement accuracy of focal cartilage defects from MRI and correlation of MRI graded lesions with histology: a preliminary study. Osteoarthritis Cartilage. 2003;11:483–493
  26. Drape JL, Pessis E, Auleley GR, et al. Quantitative MR imaging evaluation of chondropathy in osteoarthritic knees. Radiology. 1998;208:49–55
  27. Ding C, Cicuttini F, Jones G. Tibial subchondral bone size and knee cartilage defects: relevance to knee osteoarthritis. Osteoarthritis Cartilage. 2007;15:479–486
  28. Mastbergen SC, Bijlsma JW, Lafeber FP. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study. Osteoarthritis Cartilage. 2005;13:519–526
  29. Tindall EA, Sharp JT, Burr A, et al. A 12-month, multicenter, prospective, open-label trial of radiographic analysis of disease progression in osteoarthritis of the knee or hip in patients receiving celecoxib. Clin Ther. 2002;24:2051–2063
  30. Sawitzke AD, Shi H, Finco MF, et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum. 2008;58:3183–3191
  31. Fosbol EL, Gislason GH, Jacobsen S, et al. The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidemiol Drug Saf. 2008;17:822–833

 Funding: National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; University of Tasmania Grant-Institutional Research Scheme.

 Conflict of Interest: Dr. Jones has worked as a consultant, speaker, and clinical trialist with Pfizer, MSD, Roche, and Novartis, all of which manufacture NSAIDs. However, none of these companies had any input into the writing of this article. Other authors have nothing to declare.

 Authorship: All authors had access to the data in the study. Study design: Ding, Cicuttini, Jones. Acquisition of data: Ding, Jones. Analysis and interpretation of data: Ding, Cicuttini, Jones. Manuscript preparation: Ding, Cicuttini, Jones. Statistical analysis: Ding, Jones.

PII: S0002-9343(09)00341-6

doi: 10.1016/j.amjmed.2009.03.022

The American Journal of Medicine
Volume 122, Issue 9 , Pages 836-842 , September 2009

Article Tools

* Image Usage & Resolution